Yahoo · Sep 10, 2026
Hercules Capital (HTGC) Suffers a Larger Drop Than the General Market: Key Insights
Hercules Capital (HTGC) concluded the recent trading session at $17.39, signifying a -1.25% move from its prior day's close.
HT
NYSE · HTGC
Hercules Capital, Inc.
Financial Services · Asset Management
$17.64
Down-$0.07 (-0.40%)
Updated Sep 17, 2026, 1:06 AM
SID Score
5.7/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 3.43B
- P/E ratio
- 17.94
- Dividend yield
- 9.07%
- 52-week range
- $13.70 – $19.46
- Volume
- 1.27M
- Avg. volume
- 1.25M
Price performance
HTGC price history
1M range · 19 trading sessions · Daily adjusted prices
HTGC closed at $17.64 after 19 trading sessions, up 4.38% for the selected period.
- Last close
- $17.64
- Period change
- +4.38%
- Period low
- $16.90
- Period high
- $17.72
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $17.50 | $17.715 | $17.50 | $17.64 | 1.27M |
| Sep 14, 2026 | $17.45 | $17.66 | $17.43 | $17.58 | 1M |
| Sep 11, 2026 | $17.50 | $17.6786 | $17.345 | $17.41 | 860.56K |
| Sep 10, 2026 | $17.61 | $17.73 | $17.38 | $17.39 | 1.21M |
| Sep 9, 2026 | $17.75 | $17.7963 | $17.445 | $17.61 | 1.56M |
| Sep 8, 2026 | $17.67 | $17.785 | $17.60 | $17.72 | 2.2M |
| Sep 4, 2026 | $17.62 | $17.80 | $17.60 | $17.63 | 744.31K |
| Sep 3, 2026 | $17.80 | $17.9347 | $17.485 | $17.72 | 1.22M |
| Sep 2, 2026 | $17.70 | $17.785 | $17.64 | $17.71 | 1.22M |
| Sep 1, 2026 | $17.85 | $17.93 | $17.63 | $17.67 | 1.52M |
| Aug 31, 2026 | $17.44 | $17.84 | $17.43 | $17.64 | 1.19M |
| Aug 28, 2026 | $17.51 | $17.675 | $17.45 | $17.48 | 1.39M |
| Aug 27, 2026 | $17.64 | $17.74 | $17.505 | $17.52 | 3.55M |
| Aug 26, 2026 | $17.56 | $17.715 | $17.51 | $17.64 | 1.38M |
| Aug 25, 2026 | $17.48 | $17.64 | $17.42 | $17.59 | 1.5M |
| Aug 24, 2026 | $17.16 | $17.535 | $17.12 | $17.50 | 1.84M |
| Aug 21, 2026 | $17.14 | $17.17 | $16.98 | $17.13 | 1.91M |
| Aug 20, 2026 | $16.92 | $17.11 | $16.865 | $17.03 | 1.68M |
| Aug 19, 2026 | $16.70 | $16.93 | $16.70 | $16.90 | 1.36M |
Latest HTGC news
The latest Smart Investors Daily articles mentioning HTGC.
Stock researchCompany · Overview
HTGC research
Overview
Company profile and research snapshot.
Company profile
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $19.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 1, 2026 | UBS | Buy | — |
| Jul 31, 2026 | Ladenburg Thalmann | Buy | — |
| May 18, 2026 | UBS | Neutral | — |
| May 6, 2026 | Piper Sandler | Neutral | — |
| Apr 22, 2026 | Citizens | Market Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 9, 2026
How Large Does Your Portfolio Need to Be to Generate $12,500 a Month?
A seven-holding portfolio promising $12,500 a month sounds straightforward until you examine whose money is actually funding some of those distributions, and why the highest-yielding positions have the weakest claim to keeping their promises.
Yahoo · Sep 9, 2026
Is Hercules Capital (HTGC) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Hercules Capital (HTGC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SeekingAlpha · Sep 8, 2026
Hercules Capital: Why It Deserves A Premium To NAV Valuation
Hercules Capital (HTGC) outlook: biotech/healthcare rebound, rate upside to NII/EPS, low-cost edge, and attractive valuation vs BDC peersâread now.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
